• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Cosco Shipping Hldgs CO
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

192.82 -7.84 (-3.90%)
Delayed Quote Updated: 4:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,954,294
Open 197.57
Bid (Size) 193.25 (500)
Ask (Size) 200.00 (100)
Prev. Close 200.66
Today's Range 191.25 - 199.24
52wk Range 112.65 - 309.35
Shares Outstanding 151,200,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027? ↗
November 19, 2026
Natera's revenue growth tops 37%, but Tempus AI trades at a lower forward multiple, and the balance sheets and cash flow stories diverge sharply. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question ↗
November 17, 2026
Illumina (NASDAQ:ILMN) is seeing strong demand for its sequencing instruments from clinical customers, while remaining cautious about a recovery in research spending, Chief Financial Officer Ankur... 
Via MarketBeat
Topics Artificial Intelligence

Performance

52-Week Range 37.7% below 52-week high
192.82
112.6552W Low 309.3552W High
1 Week 11.0% below 1-week high
191.251W Low 216.581W High

Illumina, Inc. - Common Stock (ILMN) traded between $112.65 and $309.35 over the past 52 weeks and last traded at $192.82, 37.7% below its 52-week high. Over the past week it ranged between $191.25 and $216.58.

Past 12 Months
-2.6%
-28.4%
-13.6%
+32.8%
+43.5%
+55.7%
1W -$5.18
1M -$76.58
3M -$30.40
6M +$47.59
YTD +$58.47
1Y +$68.97

ILMN was +55.7% over the past year, +32.8% over six months, +43.5% year to date, -2.6% in the last week.

12 Months vs Market
ILMN
+55.7%
DIA
+4.0%
SPY
+4.7%
QQQ
+3.1%
IWM
+8.9%

Over the past 12 months ILMN returned +55.7% versus DIA (Dow) +4.0%, SPY (S&P 500) +4.7%, QQQ (Nasdaq 100) +3.1% and IWM (Russell 2000) +8.9%.

Volume & Liquidity 0.69× 3-mo avg
Today 1,954,294 3-mo avg 2.8M
1W
1.7M
1M
2.1M
3M
2.8M
6M
2.4M
YTD
2.2M
1Y
2.1M

ILMN most recently traded 1,954,294 shares against a 3-month average daily volume of 2.8M.

More News

Read More
News headline image
Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists ↗
November 10, 2026
Via MarketBeat
Topics Artificial Intelligence
Illumina (NASDAQ:ILMN) Q3 Revenue Miss Overshadows EPS Beat ↗
October 29, 2026
Via Chartmill
News headline image
GRAIL (GRAL) Q3 2026 Earnings Call Transcript ↗
November 05, 2026
Via The Motley Fool
Topics Earnings
News headline image
Waters Q3 Earnings Call Highlights ↗
November 04, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
10x Genomics (TXG) reports Q3: everything you need to know ahead of earnings
November 03, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
PacBio (PACB) reports Q3: everything you need to know ahead of earnings
November 02, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
The top 5 analyst questions from Illumina’s Q3 earnings call
October 31, 2026
Via StockStory
Topics Earnings
S&P 500 Top Movers: Gainers and Losers in Today's US Session ↗
October 30, 2026
Via Chartmill
Topics Stocks
S&P 500 Top Movers: Gainers and Losers in Today's Session ↗
October 30, 2026
Via Chartmill
Topics Stocks
News headline image
Why Illumina (ILMN) shares are getting obliterated today
October 30, 2026
Via StockStory
Topics Artificial Intelligence Earnings World Trade
News headline image
ILMN Q3 deep dive: clinical demand and AI initiatives drive outlook amid revenue miss
October 30, 2026
Via StockStory
Topics Artificial Intelligence
S&P 500 Gap Movers for October 30, 2026 ↗
October 30, 2026
Via Chartmill
Topics Stocks
News headline image
Illumina (ILMN) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics Earnings World Trade
S&P 500 Premarket Gainers and Losers on Oct. 30, 2026 ↗
October 30, 2026
Via Chartmill
Topics Stocks
News headline image
Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Up ↗
October 30, 2026
Via Investor's Business Daily
Topics Artificial Intelligence World Trade
News headline image
Illumina Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings World Trade
After-Hours S&P 500 Movers: Mondelez and FedEx Freight Gain, Intel and Reddit Fall ↗
October 29, 2026
Via Chartmill
Topics Stocks
News headline image
Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16%
October 29, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
What to expect from Illumina’s (ILMN) Q3 earnings
October 27, 2026
Via StockStory
News headline image
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? ↗
October 27, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT? ↗
October 26, 2026
Via The Motley Fool
Topics ETFs
News headline image
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy? ↗
October 26, 2026
Via The Motley Fool
Topics ETFs
News headline image
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? ↗
October 25, 2026
Via The Motley Fool
Topics ETFs

Frequently Asked Questions

Is Illumina, Inc. - Common Stock publicly traded?
Yes, Illumina, Inc. - Common Stock is publicly traded.
What exchange does Illumina, Inc. - Common Stock trade on?
Illumina, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Illumina, Inc. - Common Stock?
The ticker symbol for Illumina, Inc. - Common Stock is ILMN on the Nasdaq Stock Market
What is the current price of Illumina, Inc. - Common Stock?
The current price of Illumina, Inc. - Common Stock is 192.82
When was Illumina, Inc. - Common Stock last traded?
The last trade of Illumina, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Illumina, Inc. - Common Stock?
The market capitalization of Illumina, Inc. - Common Stock is 29.15B
How many shares of Illumina, Inc. - Common Stock are outstanding?
Illumina, Inc. - Common Stock has 29B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap